Authors:
RATANAWICHITRASIN A
LEVY L
MYLES J
CROWE JP
Citation: A. Ratanawichitrasin et al., EXPERIENCE WITH LYMPHATIC MAPPING IN BREAST-CANCER USING ISOSULFAN BLUE-DYE, Journal of women's health, 7(7), 1998, pp. 873-877
Authors:
GREEN JRB
GIBSON JA
KERR GD
SWARBRICK ET
HOLDSWORTH CD
LOBO AJ
CROWE JP
SCHOFIELD KJ
TAYLOR MD
Citation: Jrb. Green et al., MAINTENANCE TREATMENT WITH BALSALAZIDE PROVIDES MORE EFFECTIVE CONTROL OF NOCTURNAL SYMPTOMS OF ULCERATIVE-COLITIS (UC) THAN DELAYED RELEASE MESALAZINE, Gut, 42, 1998, pp. 167-167
Authors:
GREEN JRB
GIBSON JA
KERR GD
SWARBRICK ET
HOLDSWORTH CD
LOBO AJ
CROWE JP
SCHOFIELD KJ
TAYLOR MD
Citation: Jrb. Green et al., MAINTENANCE TREATMENT WITH BALSALAZIDE PROVIDES MORE EFFECTIVE CONTROL OF NOCTURNAL SYMPTOMS OF ULCERATIVE-COLITIS (UC) THAN DELAYED-RELEASE MESALAZINE, Gastroenterology, 114(4), 1998, pp. 4046-4046
Authors:
AXON ATR
OMORAIN CA
BARDHAN KD
CROWE JP
BEATTIE AD
THOMPSON RPH
SMITH PM
HOLLANDERS FD
BARON JH
LYNCH DAF
DIXON MF
TOMPKINS DS
BIRRELL H
GILLON KRW
Citation: Atr. Axon et al., RANDOMIZED DOUBLE-BLIND CONTROLLED-STUDY OF RECURRENCE OF GASTRIC-ULCER AFTER TREATMENT FOR ERADICATION OF HELICOBACTER-PYLORI INFECTION, BMJ. British medical journal, 314(7080), 1997, pp. 565-568
Citation: Jp. Crowe, AN UPDATE ON BREAST-CANCER - EVOLVING TREATMENTS AND PERSISTENT QUESTIONS, Cleveland Clinic journal of medicine, 63(1), 1996, pp. 48-56
Citation: Me. Stark et Jp. Crowe, BREAST-CANCER EVALUATION AND FOLLOW-UP - A SURVEY OF THE OHIO CHAPTEROF THE AMERICAN-COLLEGE-OF-SURGEONS, The American surgeon, 62(6), 1996, pp. 458-460
Authors:
MORGAN MC
WEAVER MG
CROWE JP
ABDULKARIM FW
Citation: Mc. Morgan et al., DIABETIC MASTOPATHY - A CLINICOPATHOLOGICAL STUDY IN PALPABLE AND NONPALPABLE BREAST-LESIONS, Modern pathology, 8(4), 1995, pp. 349-354
Authors:
BATE CM
BOOTH SN
CROWE JP
MOUNTFORD RA
KEELING PWN
HEPWORTHJONES B
TAYLOR MD
RICHARDSON PDI
MCINYRE PB
MCFARLAND RJ
GREEN JRB
THOMPSON RPH
ROSE JDR
BEVAN G
DANESHMEND TK
CALAM J
OGORMAN T
CLARKE DN
SHREEVE DR
SCHILLER KF
KRASNER N
FOSTER DN
SMITH PM
BATESON MC
BERESFORD E
HEWETT S
Citation: Cm. Bate et al., OMEPRAZOLE 10-MG OR 20-MG ONCE-DAILY IN THE PREVENTION OF RECURRENCE OF REFLUX ESOPHAGITIS, Gut, 36(4), 1995, pp. 492-498
Citation: Jp. Crowe et al., POSITRON EMISSION TOMOGRAPHY AND BREAST MASSES - COMPARISON WITH CLINICAL, MAMMOGRAPHIC, AND PATHOLOGICAL FINDINGS, Annals of surgical oncology, 1(2), 1994, pp. 132-140
Authors:
BATE CM
BOOTH SN
CROWE JP
HEPWORTHJONES B
TAYLOR MD
RICHARDSON PDI
Citation: Cm. Bate et al., DOES 40 MG OMEPRAZOLE DAILY OFFER ADDITIONAL BENEFIT OVER 20 MG DAILYIN PATIENTS REQUIRING MORE THAN 4 WEEKS OF TREATMENT FOR SYMPTOMATIC REFLUX ESOPHAGITIS, Alimentary pharmacology & therapeutics, 7(5), 1993, pp. 501-507
Citation: Lp. Adler et al., EVALUATION OF BREAST MASSES AND AXILLARY LYMPH-NODES WITH [F-18] 2-DEOXY-2-FLUORO-D-GLUCOSE PET, Radiology, 187(3), 1993, pp. 743-750